Parametry laboratoryjne: CAS: 137525-51-0 Sekwencja aminokwasowa: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-u-Val Masa czsteczkowa: ~1419,5 g/mol Wzr sumaryczny: CHNO Rozpuszczalno: w wodzie, roztworach buforowych i DMSO Inne nazwy: Body Protection Compound 15, PL 14736 Numer UNII: Q33RRK9I7S Przeznaczenie Peptydy oferowane w tej kategorii przeznaczone s wycznie do bada laboratoryjnych, w tym bada biochemicznych, biologii molekularnej, farmakologii eksperymentalnej oraz biotechnologii
doi: 10.3389/fcimb.2026.1752304 Received 23 November 2025 Revised 12 January 2026 Accepted 31 January 2026 Published 19 February 2026 Volume 16 - 2026 Edited by Teclegiorgis Gebremariam, Lundquist Institute for Biomedical Innovation, United States Reviewed by Fatemeh Ahangarkani, 4cyte Pathology, Australia Sanam Dolati, Lundquist Institute for Biomedical Innovation, United States Updates Copyright 2026 Wu, Jiang, Wang, Chen, Chen and Da
Beloranib may also cause robust weight loss and hypophagia in rats with hypothalamic and genetic obesity (235)
A study with bipolar patients and schizophrenia subjects also observed no robust differences between patients and controls either for allele frequencies or genotype distribution of C677T polymorphism 66
These results demonstrate the potential of the pyrophosphate diester linker for the future development of therapeutically practical ADCs